In dialysis patients, elevated serum NT-pro-BNP is associated with hypervolemia and mortality.[21] BNP plays a regulatory role against increased ventricular volume load, vasoconstriction, sodium retention, and RAS activation.[22,23] Natriuretic peptides can inhibit RAS, leading to decreased BMD. Here, NPPB is linked to Hypervolemia.